Deverra Therapeutics, Inc.
Deverra Therapeutics, Inc. is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 1 tracked investor.
About Deverra Therapeutics, Inc.
Deverra Therapeutics, Inc. is a company headquartered in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Deverra Therapeutics develops allogeneic, off-the-shelf universal donor cellular immunotherapies derived from umbilical cord blood cells for treating cancer and infectious diseases, advancing multiple clinical-stage programs including stem/progenitor cell and immune effector cell therapies.
Explore Deverra Therapeutics, Inc.'s full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.